BACKGROUND: Eosinophils in asthmatic airways are associated with risk of exacerbations. The most common cause of asthma exacerbations is viral respiratory infections, particularly human rhinovirus (HRV). OBJECTIVE: To determine the mechanism by which eosinophils may influence virus-induced responses. METHODS: We used an in vitro coculture model of primary human eosinophils and the BEAS-2B epithelial cell line either stimulated with HRV1A infection or polyinosinic-polycytidylic acid (poly[I:C]). The messenger RNA (mRNA) expression of interferon (IFN) β1 and IFN-λ1 was assessed by quantitative reverse-transcriptase polymerase chain reaction and the protein level of IFN- λ1 by enzyme-linked immunosorbent assay. RESULTS: Both poly(I:C) and HRV1A infection induced BEAS-2B expression of IFN-β1 and IFN-λ1 mRNA. Coculture of eosinophils resulted in suppression of poly(I:C)-stimulated IFN-β1 and IFN-λ1 mRNA expression (2.5-fold and 3.6-fold less, respectively). Separation of cells did not block eosinophil regulatory activity. Coculture of eosinophils with HRV1A-infected BEAS-2B cells also suppressed IFN-β1 and IFN-λ1 mRNA (5.7-fold and 5.0-fold less, respectively) and reduced IFN-λ1 protein secretion (1.6-fold decrease). This corresponded to a 34% increase in the quantity of HRV1A virus RNA on coculture with eosinophils. Recombinant transforming growth factor β suppressed IFN-λ1 from HRV1A-infected BEAS-2B cells. Coculture of eosinophils and BEAS-2B cells induced transforming growth factor β secretion, which may mediate suppression of HRV-induced interferon expression. CONCLUSION: Eosinophils suppressed HRV-induced expression of interferons from epithelial cells, resulting in increased quantity of HRV. This represents one mechanism for interaction between allergic inflammation and innate immunity.
BACKGROUND: Eosinophils in asthmatic airways are associated with risk of exacerbations. The most common cause of asthma exacerbations is viral respiratory infections, particularly human rhinovirus (HRV). OBJECTIVE: To determine the mechanism by which eosinophils may influence virus-induced responses. METHODS: We used an in vitro coculture model of primary human eosinophils and the BEAS-2B epithelial cell line either stimulated with HRV1Ainfection or polyinosinic-polycytidylic acid (poly[I:C]). The messenger RNA (mRNA) expression of interferon (IFN) β1 and IFN-λ1 was assessed by quantitative reverse-transcriptase polymerase chain reaction and the protein level of IFN- λ1 by enzyme-linked immunosorbent assay. RESULTS: Both poly(I:C) and HRV1Ainfection induced BEAS-2B expression of IFN-β1 and IFN-λ1 mRNA. Coculture of eosinophils resulted in suppression of poly(I:C)-stimulated IFN-β1 and IFN-λ1 mRNA expression (2.5-fold and 3.6-fold less, respectively). Separation of cells did not block eosinophil regulatory activity. Coculture of eosinophils with HRV1A-infected BEAS-2B cells also suppressed IFN-β1 and IFN-λ1 mRNA (5.7-fold and 5.0-fold less, respectively) and reduced IFN-λ1 protein secretion (1.6-fold decrease). This corresponded to a 34% increase in the quantity of HRV1A virus RNA on coculture with eosinophils. Recombinant transforming growth factor β suppressed IFN-λ1 from HRV1A-infected BEAS-2B cells. Coculture of eosinophils and BEAS-2B cells induced transforming growth factor β secretion, which may mediate suppression of HRV-induced interferon expression. CONCLUSION: Eosinophils suppressed HRV-induced expression of interferons from epithelial cells, resulting in increased quantity of HRV. This represents one mechanism for interaction between allergic inflammation and innate immunity.
Authors: Loren C Denlinger; Ron L Sorkness; Wai-Ming Lee; Michael D Evans; Michele J Wolff; Sameer K Mathur; Gina M Crisafi; Katie L Gaworski; Tressa E Pappas; Rose F Vrtis; Elizabeth A Kelly; James E Gern; Nizar N Jarjour Journal: Am J Respir Crit Care Med Date: 2011-11-01 Impact factor: 21.405
Authors: Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern Journal: Mucosal Immunol Date: 2009-08-26 Impact factor: 7.313
Authors: Lei Shi; David M Manthei; Arturo G Guadarrama; Lisa Y Lenertz; Loren C Denlinger Journal: Am J Respir Cell Mol Biol Date: 2012-04-05 Impact factor: 6.914
Authors: Jennifer P DeMore; Elizabeth H Weisshaar; Rose F Vrtis; Cheri A Swenson; Michael D Evans; Allison Morin; Elizabeth Hazel; Jack A Bork; Sujani Kakumanu; Ronald Sorkness; William W Busse; James E Gern Journal: J Allergy Clin Immunol Date: 2009-07-12 Impact factor: 10.793
Authors: Nicole Bedke; David Sammut; Ben Green; Valia Kehagia; Patrick Dennison; Gisli Jenkins; Amanda Tatler; Peter H Howarth; Stephen T Holgate; Donna E Davies Journal: PLoS One Date: 2012-09-06 Impact factor: 3.240
Authors: Ian D Pavord; Stephanie Korn; Peter Howarth; Eugene R Bleecker; Roland Buhl; Oliver N Keene; Hector Ortega; Pascal Chanez Journal: Lancet Date: 2012-08-18 Impact factor: 79.321
Authors: Yu Z Lee; Hui M Yap; Khozirah Shaari; Chau L Tham; Mohd R Sulaiman; Daud A Israf Journal: Front Pharmacol Date: 2017-11-16 Impact factor: 5.810
Authors: Jae Woong Hwang; Ki Jeong Lee; In Hak Choi; Hye Min Han; Tae Hoon Kim; Sang Hag Lee Journal: J Allergy Clin Immunol Date: 2019-08-23 Impact factor: 10.793
Authors: Christopher McCrae; Marita Olsson; Per Gustafson; Anna Malmgren; Malin Aurell; Malin Fagerås; Carla A Da Silva; Anders Cavallin; Jonathan Paraskos; Karin Karlsson; Cecilia Wingren; Phillip Monk; Richard Marsden; Tim Harrison Journal: Clin Exp Allergy Date: 2020-11-03 Impact factor: 5.018